Arkolith/Insider Trading/VYGR/Form 4

Carter Todd Alfred

Chief Scientific OfficerVoyager Therapeutics, Inc. (VYGR) · full profile →Form 4 · filed Feb 22, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$30K
Net Open-Market Flow
-$30K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2024Sell(S)3K$7.47$25K88K
Feb 20, 2024Sell(S)602$7.68$5K91K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-026554) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML